DOCSLIB.ORG

Israel Gastroenterology Association Annual Meeting 03-05 February 2016, Hilton Hotel, Tel Aviv

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Israel Gastroenterology Association Annual Meeting 03-05 February 2016, Hilton Hotel, Tel Aviv Israel Gastroenterology Association Annual Meeting 03-05 February 2016, Hilton Hotel, Tel Aviv The Annual Scientific Meeting will take place at The Hilton Hotel Tel Aviv, Ballroom A, B&C, Lobby floor. WEDNESDAY 03.02.2016 Educational Day (sponserd by Jannesen) Ballroom C ״Plenary session - Updates in gastroenterology״ 15:00-16:40 Chairs: Eran Goldin and Alex Geller 15:00 ESD: Has the time come? Pro: Harold Jacobs, Hadassah Medical Center, Jerusalem Con: Ori Segol, Carmel Medical Center, Haifa 15:30 How to perform EMR? How and what to inject, cautery principles, snare selection Yael Kopelman, Hillel Yaffe Medical Center, Hadera 15:50 Endoscopic diagnosis and management of upper and lower GI bleeding - current guideline recommendations Ian Gralnek, HaEmek Medical Center, Afula 16:20 What's new in modern liver surgery - From minimally invasive to transplantation Ido Nachmany, Tel Aviv Sourasky Medical Center 16:40-17:00 Smoothies and donuts ״?Looking into the crystal ball - What can we expect in 2016״ 17:00-19:00 Chairs: Alex Fich and Ehud Meltzer 17:00 IBD Iris Dotan, Tel Aviv Sourasky Medical Center 17:20 Motility Jan Tack, University of Leuven, Belgium 17:40 What to do if your patient is no longer responding to PPI? Ram Dickman, Rabin Medical Center, Petah Tikva 18:00 When will HCV be eradicated in Israel - Hopes and hypes TBD 18:20 Advanced molecular based therapy for GI malignancies Dan Aderka, Sheba Medical Center, Ramat Gan 19:00-20:00 Special dinner 20:00 Danny Sanderson LIVE! THURSDAY 04.02.2016 08:45- 09:00- 09:00- Ballroom A Ballroom B Ballroom C 10:05 10:35 10:35 GI nurses program How to improve gut motility? Sexuality, functionality, pregnancy and Chairs: Rina Asuline (Sponsored by the GI Motility Society) surgery in IBD Chairs: Yosef Lisi and Roy Dekel (sponsored by the IBD society) Chairs: Eran Israeli and Eran Zittan Precedex - patients Evidence based approach to Functional female sexuality cooperation during endoscopy constipation Idan Militscher, Tel Aviv Sourasky 08:45 09:00 09:00 Mrs. Galina Grberger, Hadasa Ein Jan Tack, University of Leuven, Medical Center Carem Medical Center, Jerusalem Belgium Local and international How to treat fecal incontinence? Fecundity and sexuality developmentand progress for Yishai Ron, Tel Aviv Sourasky dysfunction in the IBD patient 09:20 09:20 09:05 IBD nurse Medical Center Ariela Shitrit, Shaare Zedek Mrs. Simona Bar, Rabin medical Medical Center in Jerusalem center, Petah Tikva Functional abdominal pain: Novel techniques in perianal HCV did we succeed to Focus on antidepressants IBD surgery 09:35 09:35 distinguish the diseases? Rita Brun, Rambam Medical Oded Zmora, Sheba Medical 09:25 Mrs. Keren Tzaref, Shiba Medical Center, Haifa Center, Ramat Gan center, Ramat Gan I am bloated and uncomfortable Approach to abdominal IBD Managing infection control in please help me doc! surgery 09:50 09:50 endoscopy unit Yehuda Ringel, Rabin Medical Petachia Reissman, Shaare 09:45 Mr. Alexander Michlin, Rambam Center, Petah Tikva Zedek Medical Center, Jerusalem Medical Center, Hiafa Chronic GI diseases post traveling 10:05 Eli Schwartz, Sheba Medical Center, Ramat Gan 10:05- The Israeli approach to 10:05 Original abstracts Tea Break 10:30 constipation: Finally we have 10:20 our own guidelines Dan Carter, Sheba Medical Center, Tel Hashomer 10:35-11:00 Tea Break 10:30- 11:00 - 11:00 - Ballroom A Ballroom B Ballroom C 13:00 12:00 12:00 Nurses program How to improve my colonoscopy skills Microbiome target Chairs: Rina Asuline (Sponsored by the Endoscopy Society) Chairs: Nitzan Mahrshak and Chairs: Yona Avni and Itamar Pomeranz Yehuda Chowers Ambulatory colonoscopy, Cholangioscopy - Who? When? Fecal microbial transplantation process review How? in Israel - where do we stand? 11:00 11:00 10:30 Mrs. Lilia Rozenfeld, Bnei-Zion Dov Wengrover, Shaare Zedek Nitsan Maharshak, Tel Aviv Medical Center, Haifa Medical Center in Jerusalem Sourasky Medical Center Tips and tricks for polypectomy - Mood disturbances and the Improving experience and what you should be doing microbiome satisfaction of children and 11:20 11:20 Fabiana Binyaminov, Meir Omry Koren, Bar-Ilan School of parents undergoing endoscopy 10:50 Medical Center, Kfar Saba Medicine procedures Mrs. Rachel Leshem Namedar, Sheba Medical Center, Ramat Gan Avoiding, recognizing and Treating fistula post bariatric The microbiota as biomarkers treating complications? surgery 11:40 11:40 for GI tumors 11:10 Iyad Khamaisi, Rambam Medical Mr. Fares Tachibash, Rambam Uri Gophna, Tel Aviv University Medical Center, Hiafa Center, Haifa IBD unit optimization 11:30 Mrs. Revital Barkan, Tel Aviv Sorasky Medical Center Support group for ibd patients - ״our experience 11:50 Mrs. Rina Assulin, Rambam Plenary session Best Original Plenary session Best Original Medical Center, Haifa abstracts abstracts 12:00 12:00 Fecal transplantation Chairs: Ian Gralnek and Revital Chairs: Ian Gralnek and Revital 12:20 Nitzan Maharcheck, Tel Aviv Kariv Kariv Sorasky Medical Center RFA procedure, the nurse role 12:40 Lena cichulin, Rabin Medical Center, Petah Tikva 13:00-14:30 LUNCH SYMPOSIUM - King Solomon Hall TAKEDA symposia TBD Chairs: Iris Dotan Management of IBD - current concepts and future directions real life experience with vedolizumabin israel Uri Kopylov, Sheba Medical Center, Tel Hasomer Therapeutic options for specific scenarios: Post infections The pregnant patient Ariela Shitrit, Shaare Zedek Medical Center, Jerusalem Colonic Crohn's disease Eran Israeli, The elderly patient Uri Kopylov, PFIZER symposia NEW ERA - Direct Oral Anti Coagulants - indications and complications Asher Winder, The coagulation expert, Director Department of Hematology, Head of Thrombosis and Hemostasis Unit, Wolfson Medical Center The gastroenterologist point of view Adi Lahat, Gastroenterology department, Sheba Medical Center TTR-FAP the importance of early diagnosis - the Gastroenterologist Impact Menachem Sade, Neurology, Wolfson Medical Center RAFA education symposium Chairs: Ram Dickman and TBD How can my paper be accepted? Jan Tak, University of Leuven, Belgium 14:45- 14:45- 14:45- Ballroom A Ballroom B Ballroom C 16:15 16:15 16:15 Pediatric gastroenterology program Obesity therapy: Tablet, scope or knife The liver is part of us Chairs: Michael Wilschanski and (Sponsored by the Nutrition Section) (Sponsored by the Israel Liver society) Ron Shaoul Chairs: Sigal Fishman and Chairs: Michal Carmieli and Yakov Maor Irit Chermesh Bariatric surgery in Israel - What Autoimmune hepatitis you should know! Ziv Ben Ari, Sheba Medical 14:45 Original abstracts 14:45 14:45 Dean Keren, Rambam Medical Center, Tel Hasomer Center, Haifa Endoscopic evaluation and Primary biliary cirrhosis - Not treatments for bariatric surgery any more 15:00 complications 15:00 Ran Tur Kaspa, Rabin Medical Mati Shnel, Tel Aviv Sourasky Center, Petah Tikva Medical Center Emerging endoscopic therapies Primary sclerosing cholangitis Diagnostic characteristics of for obesity and diabetes 15:15 15:15 Ran Oren, Hadassa Medical monogenetic IBD Alon Lang, Sheba Medical Center, Jerusalem David Wilson, Professor of Center, Ramat Gan pediatric gastroenterology and Medical treatment for obesity: Granulomatous hepatitis 15:30 nutrition, Royal Hospital for new drugs in the pipe line Rifaat Safadi, Hadassa Medical 15:30 15:30 Sick Children, Edinburgh and Gabriela Liberman, Sheba Center, Jerusalem childlike and health, University of Medical Center, Ramat Gan Edinburgh, UK Drug induced liver injury Side effects of the modern diet 15:45 15:45 Oren Shibolet, Tel Aviv Sourasky Rakefet Arieli, Nutritionist Medical Center Pathology overview in AIH, PBC Leptin - anti-leptin therapy and PSC 16:00 Arieh Gertlaer, Hebrew 16:00 Orit Pappo, Sheba Medical Universityof Jerusalem Center, Ramat Gan 16:15-16:40 Tea Break 16:40- 16:30- 16:30- Ballroom A Ballroom B Ballroom C 18:00 18:00 18:00 Pediatric Gastroenterology program Updates in viral hepatitis and beyond: Update on GI malignancies Chairs: Dan Turner and Batia Weiss (Sponsored by the Israel Liver Society) (Sponsored by the GI Oncology Society) Chairs: Ziv Ben Ari and Rifaat Safadi Chairs: Zohar Levi and Melhem Alaa Can we eradicate HBV? Pancreatic cancer, who needs Amir Shlomai, Rabin Medical screening and how? 16:40 Original abstracts 16:30 16:30 Center, Petah Tikva Erez Scapa, Tel Aviv Sourasky Medical Center HDV management Mice at the service of 16:45 Marius Braun, Rabin Medical humans: tailoring patient’s Center, Petah Tikva chemotherapy to his own Fatty liver disease unique genetic make-up 16:45 Shira Zilber-Sagi, Department of Izhak Haviv, Safed, School of 17:00 Epidemiology, Haifa University Medicine Treatment of HCC New insights into genetic 17:15 Rawi Hassan, Ha'Emek Medical testing for GI malignancies Treatment of resistant pediatric 17:05 IBD Center, Afula Hagit Baris, Rambam Medical David Wilson, Professor of Portal hypertension ascites: Center, Haifa pediatric gastroenterology and hepato - renal and minimal The cutting edges of EUS- what 17:20 nutrition, Royal Hospital for 17:30 hepatic encepalopathy we can do in 2016 and what to Sick Children, Edinburgh and Michal Carmieli-Hagai, Medical 17:25 anticipate childlike and health, University of center of Western Galilee Jesse Lachter, Rambam Medical Edinburgh, UK Center, Haifa 17:40 Original abstracts 18:00- Ballroom C 18:30 17:45 Original abstracts Chairs: Timna Naftali and Zamir Doron 18:00 Flash Abstracts (3+1) 18:30-19:30 IGA business meeting Ballroom B 18:30 We care for you our dear fellows: Report of the exams committee Haim
Load more

Recommended publications
  • Scientific Program
    www.iscort.org.il Scientific Program 08.01.2019 - 12.01.2019, Eilat, Israel The Annual Meeting of The Israeli Society for Clinical Oncology and Radiation Therapy ISCORT wishes to express its gratitude to the following companies הוועדה המארגנת for their support of the 19th ISCORT Annual Meeting: Organizing Committee ISCORT 19 נשיא הכנס: :President פרופ׳ סלומון שטמר Platinum Sponsor Salomon M. Stemmer, MD Roche מזכירת הכנס: :Secretory ד״ר ולריה סמניסטי Gold Sponsor Valeria Semenysty, MD יו"ר הרדיותרפיה: :BMS Radiation Oncology Co-Chair פרופ׳ בן קורן MSD Ben W. Corn, MD הוועדה המדעית Silver Sponsor Scientific Committee ISCORT 19 Astellas יו"ר: פרופ׳ מיכל לוטם Astrazeneca Chairman: Michal Lotem, MD ד"ר אהרון אלון Boehringer Ingelheim Aaron Allen, MD ד"ר נועם אסנה Eli Lilly Noam Asna, MD ד"ר יאיר בר ISI Jair Bar, MD PhD ד"ר יהונתן כהן Novartis Yonathan Cohen, MD PhD פרופ׳ בן קורן Pfizer Ben W. Corn, MD ד"ר אלה עברון Rafa Ella Evron, MD ד"ר דניאלה כץ Daniela Katz, MD פרופ׳ גל מרקל Bronze Sponsor Gal Markel, MD PhD ד"ר אינה אוספובט AbbVie Inna Ospovat, MD ד"ר אביבית פאר Assuta Avivit Peer, MD ד"ר רות פרץ Bayer Ruth Perets, MD PhD Bolpharma ד"ר רפאל פפר Raphael Pfeffer, MD Dexcel Pharma ד"ר קרן רובינוב Keren Rouvinov, MD Isotopia ד"ר יקטרינה שולמן Katerina Shulman, MD Medison ד"ר אמיר זוננבליק Merck Amir Sonnenblick, MD ד"ר מרק ויגודה Nanostring Marc Wygoda, MD ד"ר אלונה זר Neopharm Alona Zer, MD ד"ר אביעד זיק Oncotest-Teva Aviad Zik, MD Perrigo החברה המארגנת Sanofi Organizing Company א.מ.
    [Show full text]
  • Israel Endocrine Society
    Israel Endocrine Society Israel Endocrine Society Conference Browse the program for the upcoming event By Session All Sessions By ID 4 By Day Tuesday By Author Aizic, A. - 31 Now Viewing: All Sessions Note: The presenter's name is in bold Registration Tuesday Morning Date: Tuesday, April 9, 2013 Time: 7:30 AM - 8:00 AM Location: Oral Presentations I: Diabetes, Obesity and Metabolism Date: Tuesday, April 9, 2013 Time: 8:00 AM - 10:00 AM Location: Bareket Hall Session Chair: Benjamin Glaser Session Chair: Hannah Kanety 8:00 AM - AMPK corrects ER morphology and function in stressed pancreatic beta-cells via regulation of the ER resident protein DRP1 (ID: 25) Jakob Wikstrom (Israel) Tal Israeli (Israel) Etty Bachar-Wikstrom (Israel) Yafa Ariav (Israel) Erol Cerasi (Israel) Gil Leibowitz (Israel) 8:15 AM - Paradox In Metabolic Homeostasis: AHNAK Knockout Mice Are Resistant To Diet-Induced Obesity And Yet They Display Reduced Insulin Sensitivity (ID: 47) Maya Ramdas (Israel) Chava Harel (Israel) Natalia Krits (Israel) http://www.xcdsystem.com/ies2013/Program/index.cfm[05/04/2013 11:15:55] Israel Endocrine Society Michal Armoni, Rambam Medical Center (Israel) Eddy Karnieli, Institute of Endocrinology, Metabolism and Diabetes (Israel) 8:30 AM - Neonatal Wolfram syndrome: novel De-novo dominant mutation presenting as an unusual clinical phenotype (ID: 52) Abdulsalam Abu-Libdeh, Hadassah Hebrew University Hospital (Israel) 8:45 AM - Importance of maintaining redox potential balance in the development of type 2 diabetes (ID: 61) Tovit Rosenzweig,
    [Show full text]
  • Dear Colleagues, It Is Our Pleasure to Invite You to the Annual Meeting Of
    Dear Colleagues, It is our pleasure to invite you to the Annual Meeting of the Israel Neurosurgical Society which will be held at the Galilion Hotel, Israel. Although the main focus of the meeting will be Brain Tumors, the organizers will be happy to consider interesting talks on related subjects. Confirmed speakers to date that will share their experiences and update us in the latest developments include: Prof. Volker A. Coenen Dept. of Stereotactic and Functional Neurosurgery, University of Freiberg; Neurosurgery Clinic, Freiberg, Germany Prof. Garth Rees Cosgrov Dept. of Neurological Surgery, Brigham and Women's Hospital, Boston, MA, USA Prof. Hans Henkes Neuroradiological Clinic, Katharinenhospital, Stuttgart, Germany Prof. Robert H. Rosenwasser Dept. of Neurological Surgery, Jefferson Hospital for Neuroscience, Philadelphia, PA, USA As in previous meetings, we hope that this event will provide the opportunity to reconnect and meet with colleagues and to strengthen professional and personal ties among our members. We hope that you will be able to join us. Sincerely, Prof. Yigal Shoshann Prof. Mony Benifla Dr. Racheli Grossman President Secretary Treasurer 1 TENTATIVE TIMETABLE Wednesday, May 13, 2020 Light Lunch Afternoon Sessions Dinner Evening Social Event Thursday, May 14, 2020 Morning Sessions Lunch Afternoon Sessions Dinner Evening Social Event Friday, May 15, 2020 Morning Sessions Afternoon Sessions End and Light Lunch Meeting Secretariat Target Conferences Ltd. PO Box 51227, Tel Aviv 6713818, Israel Tel: +972 3 5175150, Fax: +972 3 5175155 e-mail: [email protected] www.israelneurosurgery.com 2 SCIENTIFIC ADVISORY COMMITTEE ON FUNCTIONAL NEUROSURGERY AND EPILEPSY Zvi Israel - Lead Advisor Dept. of Neurosurgery, Hadassah Hebrew University Medical Center, Jerusalem Roberto Spiegelmann Dept.
    [Show full text]
  • Recurrent Deep Venous Thrombosis in a Patient with Agenesis of Inferior Vena Cava
    International Journal of General Medicine Dovepress open access to scientific and medical research Open Access Full Text Article CASE REPORT Recurrent deep venous thrombosis in a patient with agenesis of inferior vena cava William Nseir1 Background: Agenesis of the inferior vena cava (IVC) as a cause of recurrent deep vein Mahmud Mahamid1 thrombosis (DVT) is uncommon. Zuhair Abu-Rahmeh2 Case: A 33-year-old male with no family history of thrombophilia, who had experienced mul- Arieh Markel3,4 tiple recurrent episodes of DVT over a 15-year period of unknown cause, was admitted into our hospital because of cellulitis in the right leg. Computer tomography with contrast of the 1Department of Internal Medicine, 2Radiology Department, Holy abdomen showed an absence of IVC. Family Hospital, Nazareth, Israel; Conclusion: Congenital absence of the IVC could be a rare risk factor for idiopathic DVT, 3 Department of Internal Medicine A, especially in young individuals. Haemek Medical Center, Afula, Israel; 4Technion, Faculty of Medicine, Haifa, Keywords: deep vein thrombosis, agenesis, inferior vena cava Israel Background Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism, has an incidence of 1 to 3 per 1000 individuals per year in Western populations.1 Congenital anomalies of the inferior vena cava (IVC) are uncommon, and have been associated with the development of venous thrombosis of the lower limbs.2 Congenital anomalies of the IVC has been reported as a risk factor for DVT, especially in individuals ,30 years old, and a concomitant thrombophilic disorder has been found in such individuals.3 We report a case of recurrent DVT in a 33-year-old man with agenesis of the IVC.
    [Show full text]
  • Curriculum Vitae – Barak Zafrir
    Curriculum Vitae – Barak Zafrir PERSONAL DETAILS Date Prepared: November 2016 Name: BARAK ZAFRIR Office Address: Cardiovascular Department, Lady Davis Carmel Medical Center 7 Michal St., Haifa, Israel. Home Address: 6/6 Moshe Dayan St. , Kiryat Tiveon , Israel Phone: +972-0522541577 Email: [email protected] FAX: +972-99560390 Place of Birth: ISRAEL Date of Birth June 11, 1974 Marital Status Married; 2 Children ACADEMIC DEGREES Faculty of Medicine, Technion, 1996-2002 M.D Medicine Israel Institute of Technology, Haifa, Israel. PROFESSIONAL EXPERIENCE 2015-present Director, Cardiac Prevention and Rehabilitation Service Carmel Medical Center, Haifa, Israel 2013-present Preventive Cardiology / Lipid Clinics (a) Carmel Medical Center, Haifa, Israel. (b) Acre, Clalit Health Services, Haifa and Western Galilee District. 1 2012-2013 Advanced Clinical/Research Fellowship: Preventive Cardiology and Cardio-metabolic Diseases Brigham & Women's Hospital, Harvard Medical School, Boston, USA, [Fellowship Director: Jorge Plutzky M.D] 2010-present Staff Cardiologist Cardiovascular Department, Carmel Medical Center, Haifa, Israel 2004-2010 Residency and Fellowship: Internal Medicine and Cardiology Carmel Medical Center, Haifa, Israel. 2003 Internship: Medicine and Surgery HaEmek Medical Center, Afula, Israel. PROFESSIONAL COURSES Oct. 2016 Advanced Course on Familial Hypercholesterolemia, European Atherosclerosis Society, Greece Dec. 2015 Hyperlipidemia Academy, Amgen Co., Geneva, Switzerland. Nov. 2014 Cardiopulmonary Exercise Testing Training Course,
    [Show full text]
  • Scientific Program
    The 63th Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery April 12-13 • 2016 • Tel Aviv, Israel SCIENTIFIC PROGRAM Paragon Israel (Dan Knassim) Paragon Tel/Fax:03-5767730/7 Israel (Dan Knassim) a Paragon Group Company [email protected] TUESDAY, APRIL 12, 2016 08:30-10:00 Interventional Cardiology I Hall A Chairs: Ariel Finkelstein, Ran Kornowski, Israel 08:30 Effect of Diameter of Drug-Eluting Stents Versus Bare-Metal Stents on Late Outcomes: a propensity score-matched analysis Amos Levi1,2, Tamir Bental1,2, Hana Veknin Assa1,2, Gabriel Greenberg1,2, Eli Lev1,2, Ran Kornowski1,2, Abid Assali1,2 1Cardiology, Rabin Medical Center, Israel 2Sackler Faculty of Medicine, Tel Aviv University, Israel 08:41 Percutaneous Valve-in-Valve Implantation for the Treatment of Aortic, Mitral and Tricuspid Structural Bioprosthetic Valve Degeneration Uri Landes1, Abid Assali1, Ram Sharoni1,2, Hanna Vaknin-Assa1, Katia Orvin1, Amos Levi1, Yaron Shapira1, Shmuel Schwartzenberg1, Ashraf Hamdan1, Tamir Bental1, Alexander Sagie1, Ran Kornowski1 1Department of Cardiology, Rabin Medical Center, Tel Aviv, Israel 2Department of Cardiac Surgery, Rabin Medical Center, Tel Aviv, Israel 08:52 Temporal Trends in Transcatheter Aortic Valve Implantation in Israel 2008-2014: Patient Characteristics, Procedural Issues and Clinical Outcome Uri Landes1, Alon Barsheshet1, Abid Assali1, Hanna Vaknin-Assa1, Israel Barbash3, Victor Guetta3, Amit Segev3, Ariel Finkelstein2, Amir Halkin2, Jeremy Ben-Shoshan2,
    [Show full text]
  • Antibiotic Treatment for Invasive Listeriosis and Patient
    Antibiotic treatment for invasive listeriosis and patient outcome: a retrospective cohort study Yaakov Dickstein1, Yonatan Oster2, Orit Shimon3, Lior Nesher4, Dafna Yahav3,5, Yonit Wiener-Well6, Regev Cohen7,8, Ronen Ben-Ami3,9, Miriam Weinberger3,10, Galia Rahav3,11, Yasmin Maor3,12, Michal Chowers3,13, Ran Nir-Paz2, Mical Paul1,8 1 Institute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel 2 Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 3 Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel 4 Infectious Disease Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beer Sheba, Israel 5 Infectious Diseases Unit, Rabin Medical Center, Beilinson hospital, Petah-Tikva, Israel 6 Infectious Disease Unit, Shaare Zedek Medical Center, Jerusalem, Israel 7 Infectious Diseases Unit, Sanz Medical Center–Laniado Hospital , Netanya, Israel 8 The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 9 Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 10 Infectious Diseases Unit, Assaf Harofeh Medical Center, Zerifin, Israel 11 Infectious Disease Unit, Sheba Medical Center, Ramat Gan, Israel 12 Infectious Disease Unit, Wolfson Medical Center, Holon, Israel 13 Infectious Diseases Unit, Meir Medical Center, Kfar Saba, Israel Cumulative survival by treatment group Background: Current treatment started within 48 hours of culture recommendations for treatment of results and continued for a minimum duration invasive listeriosis suggest ampicillin- of 7 days. Patients who died within 48 hours of based therapy with the addition of an the index culture were excluded. The primary aminoglycoside. However, several outcome was 30-day all-cause mortality.
    [Show full text]
  • December 2013 Prof. Reuven Zimlichman Chief of Medicine and Hypertension Institute, the E
    R. Zimlichman M.D. December 2013 Prof. Reuven Zimlichman Chief of Medicine and Hypertension Institute, The E. Wolfson Medical Center P.O.B. 5, Holon 58100 Israel and Head of Cardiovascular Research Institute, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel Phone: 972-3-5028614, FAX: 972-3- 5032693 e-mail: [email protected] Prof. R. Zimlichman, M.D. is presently Chief Departments of Medicine and Head of Hypertension Institute at the E. Wolfson Medical Center, Israel, he is the Director of The Brunner Cardiovascular Research Institute, Tel-Aviv University. He is also the immediate past Vice Dean and Head of School of Continuing Education, Sackler Faculty of Medicine, Tel Aviv University. Prof. Zimlichman did his fellowship in Hypertension at the Hypertension Endocrine Branch, NIH, NHLBI in Bethesda, Maryland, USA (1983 to 1986). During the following years he returned for prolonged periods of research in the Hypertension Endocrine Branch and in the Clinical Neurocardiology section. Prof. Zimlichman joined the Faculty of Health Sciences at Ben Gurion University and Soroka Medical Center in Beer Sheva, Israel. He was nominated as Chief of Clinical and Experimental Hypertension in the Faculty of Medicine and in the Medical Center. Prof. Zimlichman was nominated as Chief of Medicine in the Sheba Medical Center, Tel Hashomer, in 1989 and was nominated as Associate Professor in Medicine at the Tel Aviv University, Sackler School of Medicine in 1994. In 1991 Prof Zimlichman was nominated as Chief of Department of Medicine in the Wolfson Medical Center, and in 1998 was nominated as Chief Departments of Medicine at the Wolfson Medical Center.
    [Show full text]
  • APF Newsletter, Winter 2006 – 2007
    Winter 2006-2007 APF A Newsletter of the From The President AmericanEmergency Physicians andFellowship Disaster Preparednessfor Medicine in Israel Course News in Israel From The President Israel in Crisis Mission August 2006 would like to share with our members and donors the important by Dr. Dan Moskowitz I APF activities of the past 6 months. his past August, I had the privilege of being invited to par- 1. APF ISRAEL CRISIS FUND REPORT After placing on our T ticipate in an Emergency APF Mission to Israel with APF website and sending a special crisis appeal from Dr. Danny Laor, Board members Drs. Mike Frogel, Paul Liebman and Charles the Deputy Minister for Emergency Preparedness, on the critical Kurtzer. Dr. Boaz Tadmor organized an incredible, whirlwind needs of the Northern hospitals, it was very gratifying indeed that over $100,000 tour for us, only two days after the cessation of hostilities in was received for our Crisis Fund. All of this will be distributed to hospitals such as Israel. We were provided with a unique glimpse of the Israeli Sieff Hospital in Safed, Poriya in Tiberias, Western Galilee Medical Center in Nahariya, and Rambam Medical Center in Haifa, with the hospital CEO’s given the healthcare system under stress, including face-to-face meet- discretion as to how best to utilize these funds to help their hospital in light of the ings with top healthcare officials, as well as visits to the trau- recent crisis. matized hospitals in northern Israel. Perhaps most importantly, we visited 2. MISSION TO ISRAEL Three APF Board members, Drs.
    [Show full text]
  • THE ITALIAN-ISRAELI SUMMIT in CANCER PREVENTION and INTERVENTION June 3RD, 2015 TEL AVIV MEDICAL CENTER
    THE ITALIAN-ISRAELI SUMMIT IN CANCER PREVENTION AND INTERVENTION June 3RD, 2015 TEL AVIV MEDICAL CENTER SCIENTIFIC PROGRAM 08:00 Registration 08:45-09:00 Opening Session OPENING AND GREETINGS Cesare Hassan, Rome, Italy Nadir Arber, Tel Aviv, Israel Erwin Santo, Tel Aviv, Israel 09:00-10:20 Session I Chairs: Cesare Hassan, Italy Elizabeth Half, Israel 09:00 INTERVAL AND MISSED COLORECTAL Carlo Senore Torino, Italy 09:20 NOVEL TECHNOLOGIES OF SCREENING COLONOSCOPY Spada Cristiano, Digestive Endoscopy, Italy 09:40 A pro-active model to identify patients at high risk for familial cancer syndromes Tomer Adar, Shaare-Zedek, Jerusalem, Israel 10:00 CANCER PREVENTION IN LYNCH SYNDROME- IS IT POSSIBLE? Elizabeth Half Rambam Medical Center, Haifa, Israel 10:20 Coffee Break Session II 10:40-13:00 Chairs: Lorenzo Fuccio, Italy Yaron Niv, Israel 10:40 UNIVERSAL SCREENING FOR LYNCH SYNDROME- FEASABILITY AND MUTATIONAL STATUS IN ISRAEL Zohar Levi Rabin Medical Center, Petach Tiqva, Israel 11: 00 WHEN AND HOW TO PERFORM GENETIC TESTING FOR INHERITED POLYPOSIS SYNDROMES Revital Kariv Tel-Aviv Sourasky Medical Center, Israel 11:20 THE CLINICAL APPROACH TO PANCREATIC INCIDENTALOMA Erwin Santo Tel-Aviv Sourasky Medical Center, Israel 11:40 H. PYLORI ERADICATION IN THE PREVENTION OF GASTRIC CANCER Lorenzo Fuccio Gastroenterology Department, University of Bologna, Italy 12:00 HCC steps forward, but still a long way to go Oren Shibolet Liver Unit, Tel-Aviv Medical Center, Tel-Aviv, Israel 12:20 HEREDITARY diffuse gastric cancer Lior Katz Chaim Sheba Medical Center, Tel Hashomer, Israel 12:40 THE ENDOSCOPIC APPROCH TO EARLY BARRETT'S CANCER Fred Konikoff Meir Medical Center, Kfar-Saba, Israel 13:00-13:40 Lunch Break Session III 13:40-14:40 THE INVENTOR’S CORNER Chairs: Erwin Santo, Israel Cristiano Spada, Italy 13:40 WHY IS ISRAEL AN INOVATIVE COUNTRY? Ori Segol Carmel Medical Center, Haifa, Israel 13:50 FULL-SPECTRUM ENDOSCOPY (FUSE) Ian M.
    [Show full text]
  • BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
    BMJ Open: first published as 10.1136/bmjopen-2020-040210 on 8 February 2021. Downloaded from BMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers’ comments and the authors’ responses online. We also post the versions of the paper that were used during peer review. These are the versions that the peer review comments apply to. The versions of the paper that follow are the versions that were submitted during the peer review process. They are not the versions of record or the final published versions. They should not be cited or distributed as the published version of this manuscript. BMJ Open is an open access journal and the full, final, typeset and author-corrected version of record of the manuscript is available on our site with no access controls, subscription charges or pay-per-view fees (http://bmjopen.bmj.com). If you have any questions on BMJ Open’s open peer review process please email [email protected] http://bmjopen.bmj.com/ on September 26, 2021 by guest. Protected copyright. BMJ Open BMJ Open: first published as 10.1136/bmjopen-2020-040210 on 8 February 2021. Downloaded from PipEracillin Tazobactam versus mERoPENem for treatment of bloodstream infections caused by cephalosporin-resistant Enterobacteriaceae - a non-inferiority randomized controlled trial (PeterPen) ForJournal: peerBMJ Open review only Manuscript ID bmjopen-2020-040210 Article Type: Protocol Date Submitted
    [Show full text]
  • The 49Th Conference of the Israeli Society of Nephrology and Hypertension April 25Th - 27Th, 2013 | Dan Caesarea Hotel Scienti C Programme
    The 49th Conference of the Israeli Society of Nephrology and Hypertension April 25th - 27th, 2013 | Dan Caesarea Hotel Scientic Programme Organizing Committee Dr. Eliezer Golan, President, ISNH. Meir Medical Center, Kfar Saba Dr. Talia Weinstein, Vice-President, ISNH. Sourasky Medical Center, Tel Aviv Scientic Committee Dr. Suheir Assady, Chairperson, Rambam Health Care Campus, Haifa Dr. Talia Weinstein, Sourasky Medical Center, Tel Aviv Dr. Sydney Benchetrit, Meir Medical Center, Kfar Saba The 49th Conference of the Israeli Society of Nephrology and Hypertension April 25th - 27th, 2013 | Dan Caesarea Hotel Scientic Programme Day 1 - Thursday, April 25th, 2013 12:30 - 13:30 Reception, Exhibition & Lunch 13:30 - 13:50 Session 1 13:30 - 13:40 Greetings & Opening Remarks Dr. Suheir Assady, Dr. Eliezer Golan 13:40 - 13:50 ISNH RENAL REGISTRY (IRR) - Annual Report Dr. Eliezer Golan 13:50 - 15:15 Session 2 Chairs: Dr. Gabriel Mordochovic, Dr. David Tovbin 13:50 - 14:50 Free Communications- Dialysis and Hypertension 13:50 PERCUTANEOUS RENAL REVASCULARIZATION: A LONG TERM FOLLOW- UP OF 155 PROCEDURES Daniel Kushnir1, Jeri Marcusohn1, Alon Antebi1, Rima Sukhotnik1, and Victor Frajewicki1. 1 Department of Nephrology and Hypertension, Carmel Medical Center, Haifa. 14:00 PAIN MANAGEMENT IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: RESULTS OF ONE CENTER EXPERIENCE Isabelle Haggiag1,2, Yael Einbinder1, Jacques Bernheim 1,2 and Sydney Benchetrit1,2. 1 Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba; 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv. 14:10 RISK MANAGEMENT AND QUALITY CONTROL PARAMETERS IN ONE HEMODIALYSIS CENTER: A CLINICAL AND PATIENT CARE ATTITUDE Ze'ev Katzir1, Olga Shmain-Naidanov2, Relu Cernas1, Zvi Barnea1, Alexander Biro1, and Mona Boaz3.
    [Show full text]